Illumina Inc (ILU BE) stock market data APIs
€106.1638
-0.42(-0.4%)
as of March 18, 2026
Try our APIs with
free plan!
Illumina Inc Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for ILU.BE.
Prev. Close
106.1638
Open
105.7467
High
106.5673
Low
103.9616
52 wk Range
62.5-116.2
Market Cap
51 833 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Illumina Inc data using free add-ons & libraries
Get Illumina Inc Fundamental Data
Illumina Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Illumina Inc News
New
AI in Biotechnology Market Research and Global Forecast Report 2025-2035: Opportunities Surge Amid Predictive Modeling, Healthcare Breakthroughs and Agricultural, Environmental Advancements
Company Logo Enhanced AI adoption for predictive drug safety analytics, laboratory process automation, and cost-efficient research pipelines are fueling growth. Expansion in biological datasets, clou...
Why Illumina (ILMN) Is Up 14.3% After Launching TruPath Genome And Expanding Rare-Disease Sequencing
In late February 2026, Illumina, Inc. launched its TruPath Genome whole‑genome solution and expanded clinical sequencing services, including supporting Florida State University’s new pediatric rar...
Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics
TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases 40% increase in output...
TEM vs. ILMN: Which MedTech Stock Offers Greater Upside?
In 2026, MedTech players' success will hinge on their ability to balance near-term pressure with long-term transformation. Per a report by ZS, these players must address immediate operational, financi...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
